Should adrenaline (epinephrine) be administered in a patient with severe COPD presenting with a silent chest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Do Not Give Adrenaline for Severe Silent Chest in COPD

Adrenaline (epinephrine) is NOT indicated for severe COPD exacerbations with silent chest and should be avoided. The appropriate management is aggressive nebulized bronchodilators (beta-agonists and anticholinergics), systemic corticosteroids, and preparation for mechanical ventilation.

Why Adrenaline is Inappropriate in COPD

Wrong Clinical Context

Silent chest in COPD represents life-threatening bronchospasm with impending respiratory failure, not anaphylaxis. The established COPD guidelines make no mention of adrenaline/epinephrine for acute exacerbations 1. Adrenaline is reserved for anaphylaxis 2, not obstructive lung disease exacerbations.

Potential Harm in COPD Patients

COPD patients typically have significant cardiovascular comorbidities. Adrenaline can precipitate serious complications 3:

  • Cardiac arrhythmias - particularly dangerous in patients with underlying heart disease
  • Myocardial ischemia - from increased oxygen demand and coronary vasoconstriction
  • Severe hypertension - worsening cardiac strain
  • Lactic acidosis - compounding existing respiratory acidosis

One case report demonstrates the danger: a patient with cardiac dysfunction presenting as "status asthmaticus" deteriorated into cardiogenic shock after receiving epinephrine, with hemodynamics only improving after the drug was stopped 4.

Correct Management Algorithm for Silent Chest in COPD

Immediate Actions (First 5 Minutes)

  1. Recognize impending respiratory arrest - silent chest means minimal air movement despite maximal effort
  2. Call for senior help immediately and prepare for intubation
  3. Controlled oxygen therapy - target SpO2 88-92% via Venturi mask to avoid CO2 retention 1

Pharmacological Management

First-line bronchodilators (administer immediately) 1:

  • Nebulized salbutamol 5 mg (or terbutaline 10 mg)
  • PLUS nebulized ipratropium 0.5 mg
  • Drive nebulizers with compressed air (not oxygen) if PaCO2 elevated or respiratory acidosis present
  • Continue oxygen at 1-2 L/min via nasal prongs during nebulization
  • Repeat every 5-10 minutes if no response

Systemic corticosteroids 1:

  • Hydrocortisone 100 mg IV (oral route not possible in extremis)
  • Or prednisolone 30 mg if patient can swallow

If no response after 2-3 nebulizer treatments 1:

  • IV aminophylline 0.5 mg/kg/hour continuous infusion
  • Monitor theophylline levels daily
  • Note: Limited evidence for effectiveness but reasonable to try before intubation

Ventilatory Support Decision

Prepare for mechanical ventilation if 1:

  • pH <7.26 with rising PaCO2
  • Failure to respond to maximal bronchodilator therapy within 30-60 minutes
  • Deteriorating consciousness
  • Exhaustion

Consider non-invasive ventilation (NIV) first if:

  • Patient alert and cooperative
  • Not excessive secretions
  • pH 7.26-7.35

Proceed directly to intubation if:

  • Cardiac arrest imminent
  • Severe altered mental status
  • Unable to protect airway

Critical Pitfalls to Avoid

Do NOT Use Adrenaline

The only scenarios where adrenaline might be considered in respiratory emergencies are:

  • Anaphylaxis with bronchospasm 2 - but this is a different diagnosis entirely
  • Post-intubation bronchospasm refractory to all other measures 5, 6 - administered via endotracheal tube in already-intubated patients as last resort

Do NOT Delay Ventilatory Support

Silent chest represents near-total airway obstruction. If bronchodilators don't work within 30-60 minutes, continuing the same approach while the patient deteriorates is futile. The BTS guidelines emphasize early consideration of ventilatory support 1.

Do NOT Use High-Flow Oxygen Unchecked

COPD patients with hypercapnia can develop worsening respiratory acidosis with uncontrolled oxygen 1. Target SpO2 88-92% and recheck arterial blood gases within 60 minutes.

Monitoring Requirements

  • Arterial blood gases - on arrival, at 60 minutes, and with any clinical deterioration 1
  • Continuous pulse oximetry - maintain SpO2 88-92%
  • Cardiac monitoring - watch for arrhythmias from bronchodilators
  • Peak airway pressures if mechanically ventilated

Summary of Evidence Quality

The guideline evidence 1 consistently supports nebulized bronchodilators and systemic corticosteroids as first-line therapy. While these are older guidelines (1997), they represent consensus expert opinion from major respiratory societies (BTS, ERS). Notably absent from all COPD guidelines is any recommendation for adrenaline/epinephrine in acute exacerbations. The anaphylaxis guideline 2 and drug labels 3 confirm adrenaline is for anaphylaxis, not COPD. Case reports of adrenaline use in bronchospasm 5, 6 describe only post-intubation scenarios as last-resort measures, not pre-hospital or emergency department management of COPD.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.